TE_38963
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | HERVS71 |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 1.13 |
| Counts of samples | TCGA_tumor:0; TCGA_normal:0; GTEx:0 |
| TSS | chrY(-):16387222 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38963.1 | - | Intergenic | Non-coding | Non-coding | chrY(-):16381874,16381894,16383093,16383318,16387142,16387223 |
| teRNA_38963.2 | - | Intergenic | Non-coding | Non-coding | chrY(-):16381874,16381894,16383093,16385139,16387142,16387223 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
